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Thermodynamic and computational studies on the binding of
p53-derived peptides and peptidomimetic inhibitors to HDM2
Abstract
Helix power: The binding interactions of linear and constrained beta-hairpin-shaped peptides with
HDM2 were compared by using experimental and theoretical methods. The entropic advantages enjoyed
by the constrained peptides were found to be largely offset by reduced enthalpic contributions to binding
of the cyclic mimetics. Formation of hydrogen bonds upon helix folding could contribute significantly
to the enhanced enthalpy observed in binding of the linear peptides.The human double minute 2 protein
(HDM2) binds a short peptide derived from the N terminus of the tumor-suppressor protein, p53. This
peptide (p53 residues 15-29) is flexible in free solution, but upon binding to HDM2 it folds into an
amphipathic alpha-helical conformation. Three residues along one face of the p53 helix (Phe19, Trp23,
and Leu26) dock into hydrophobic pockets on the surface of HDM2. A conformationally constrained
cyclic beta-hairpin peptidomimetic of p53, with residues Phe1, 6-chloro-Trp3, and Leu4 in one strand of
the beta-hairpin, was shown earlier to dock into the same pockets on HDM2. Here, we show by
isothermal titration calorimetry that the entropy loss upon binding of the constrained peptide to HDM2
is, as would be expected, much lower (TDeltaS approximately 10 kcal mol(-1) at 300 K) than that for
the linear peptide. However, the entropic advantage enjoyed by the constrained peptide is largely offset
by a reduced enthalpic contribution, relative to the linear peptide, to binding of the cyclic mimetic. To
explore the electronic nature of the interactions between the energetically important residues in each
ligand and HDM2, hybrid quantum mechanical and electrostatic Poisson-Boltzmann computational
studies were performed. The calculations reveal that significant stabilizing van der Waals interactions
and polarization effects occur between the Trp side chain in each ligand and aromatic and aliphatic
residues in HDM2. These stabilizing interactions are enhanced when a 6-chloro substituent is
incorporated into the Trp, in agreement with the experimental studies. In addition, the calculations
suggest that at least one stabilizing hydrogen bond is formed, between the Trp indole-NH in both
ligands and HDM2. Other hydrogen-bonding interactions also arise, however, along the alpha-helical
backbone of the linear peptide upon binding to HDM2, but are not mimicked in the constrained
inhibitor-HDM2 complex. The formation of these hydrogen bonds upon helix folding could contribute
significantly to the enhanced enthalpy observed in binding of the linear peptide to HDM2.
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Abstract 
The human double minute 2 protein (HDM2) binds a short peptide derived from the N-
terminus of the tumor suppressor protein p53. The peptide (p53 residues 15-29) is flexible in 
free solution but upon binding to HDM2 folds into an amphipathic α-helical conformation. 
Three residues along one face of the p53 helix (Phe19, Trp23 and Leu26) dock into 
hydrophobic pockets on the surface of HDM2. A conformationally constrained cyclic ß-
hairpin peptidomimetic of p53, with residues Phe1, 6-chloro-Trp3 and Leu4 in one strand of 
the ß-hairpin, was shown earlier to dock into the same pockets on HDM2. Here we show by 
isothermal titration calorimetry that, as expected, the entropy loss upon binding of the 
constrained peptide to HDM2 is much lower (TΔS≈10 kcal/mol at 300 K) than that for the 
linear peptide. However, the entropic advantage enjoyed by the constrained peptide is largely 
offset by a reduced enthalpic contribution to binding the cyclic mimetic compared to the 
linear peptide. To explore the electronic nature of the interactions between the energetically 
important residues in each ligand and HDM2, hybrid quantum mechanical and electrostatic 
Poisson-Boltzmann computational studies were performed. The calculations reveal that 
significant stabilizing van der Waals interactions and polarization effects occur between the 
Trp side chain in each ligand and aromatic and aliphatic residues in HDM2. These stabilizing 
interactions are enhanced when a 6-chloro-substituent is incorporated into Trp, in agreement 
with the experimental studies. In addition, the calculations suggest that at least one stabilizing 
hydrogen bond is formed, between the Trp indole-NH in both ligands and HDM2. Other 
hydrogen bonding interactions also arise, however, along the α-helical backbone of the linear 
peptide upon binding to HDM2, which are not mimicked in the constrained inhibitor-HDM2 
complex. The formation of these hydrogen bonds upon helix folding may contribute 
significantly to the enhanced enthalpy observed in binding of the linear peptide to HDM2. 
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Introduction 
The interaction of p53 with the human equivalent of the mouse double minute 2 protein 
(HDM2) has become an interesting model system for the design of new protein-protein 
interaction inhibitors.[1] Such studies have been spurred on by the important antitumor 
activity of the transcription factor p53, which functions to prevent the emergence and 
propagation of cancer-prone cells.[2] Inhibitors of the p53/HDM2 interaction have also 
attracted pharmaceutical interest for their potential value in cancer therapy.[3, 4] 
 HDM2 binds a short N-terminal segment of p53 (residues 15-29) in an amphipathic 
α-helical conformation with a dissociation constant (KD) of about 600 nM.[5] An X-ray 
structure (PDB 1YCR) reveals side chains of three residues (Phe19, Trp23 and Leu26), aligned 
along one face of the p53 helix, which dock into hydrophobic pockets on the surface of 
HDM2 (Figure-1). Two hydrogen bonds between the ligand and the protein are also 
identified, one between the Phe19 backbone amide NH of p53 and the carbonyl group of the 
Gln72 side chain in HDM2, and another between the p53 Trp23 indole NH and the HDM2 
Leu54 backbone carbonyl. 
 A large number of peptidic and small molecule p53/HDM2 inhibitors have been 
described in recent years (reviewed in[1, 4]), which target the p53 binding pockets on HDM2. 
One example is a linear phage-derived peptide (1) (Figure-2), which inhibits the p53-HDM2 
interaction with an IC50 = 8.9 µM by competition ELISA.[6] Optimization of this lead gave 
the peptide 2 with an IC50 = 314 nM. A further significant increase in affinity was achieved 
by incorporating a halogen at the 6 position of the indole moiety of tryptophan. This 
discovery was prompted by a careful analysis of the p53-HDM2 crystal structure,[5] which 
revealed a small cavity at the bottom of the Trp binding pocket that might be filled by a 
substituent the size of a methyl group or a chlorine atom at the indole 6-position. Indeed, 
peptides containing 6-chloro-, 6-methyl-, and 6-fluoro-tryptophan (6Cl-Trp, 6Me-Trp, 6F-
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Trp; 3-5) had significantly improved binding affinities (IC50 = 5 nM (3), 10 nM (4) and 14 
nM (5)).[6] Recently, a crystal structure of peptide 3 bound to HDM2 confirmed that the Cl 
substituent indeed binds and fills the Trp23 binding pocket.[7] Indeed, it is notable that chloro- 
and bromo-aromatic groups in many small molecule HDM2 inhibitors, including various cis-
imidazolines[4] (also called Nutlins) and benzodiazepinediones,[8] bind with their halogen 
atoms located in the Trp23 binding pocket on HDM2. 
 We reported earlier cyclic ß-hairpin peptidomimetics that mimic the α-helical epitope 
in p53 and bind to HDM2.[9, 10] The optimized mimetic 7 contains Phe1, 6Cl-Trp3 and Leu4, 
along one strand of the hairpin (Figure-3). A crystal structure of cyclic peptide 7 bound to 
HDM2 confirmed the ß-hairpin backbone conformation of the inhibitor, with the Phe1, 6Cl-
Trp3 and Leu4 side chains occupying the expected p53 binding pockets (for Phe19, Trp23 and 
Leu26) on HDM2 (Figure-1).[9] 
 In this work, we set out to compare the thermodynamic signatures and the electronic 
nature of the stabilizing interactions occurring between p53-derived linear peptides (13-15) or 
cyclic ß-hairpin inhibitors (6-8) and the p53 binding pockets on HDM2, using both 
experimental and theoretical methods. 
 
Results 
Experimental studies. The affinities of cyclic peptidomimetics and linear p53-derived 
peptides (residues 15-29) to recombinant HDM2 (rHDM2) were measured in three ways. 
First, a previously reported competitive surface plasmon resonance (SPR) binding assay,[10] 
was used to determine IC50 values. This assay involves immobilizing a biotinylated p53-
derived linear peptide (16) on a streptavidin-coated SPR biosensor surface, with rHDM2 and 
various concentrations of the inhibitor in the flow buffer. The IC50 is the concentration of 
inhibitor in flow buffer required to reduce rHDM2 binding to the surface (SPR signal) by 
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50%. Second, dissociation constants (KDs) were measured by SPR using biotinylated linear 
or cyclic peptides (10-12 and 16-18) immobilized on streptavidin-coated biosensor surfaces, 
with various concentrations of rHDM2 in the flow buffer. It was not possible to immobilize 
the rHDM2 directly on the biosensor surface without loss of biological activity. For 
biotinylation of the cyclic mimetics, a 4-hydrazino group was introduced into the pyrrolidine 
ring of the D-Pro residue (see Supporting Information), to which biotin was coupled through 
a short polyethyleneglycol linker (see Figure-3). The crystal structure of the 7-HDM2 
complex[9] showed that the 4-position in D-Pro is solvent exposed, and that a new substituent 
here is unlikely to influence HDM2 binding. Thirdly, KDs for unmodified ligands (6-8 and 
13-15) were determined by isothermal titration calorimetry (ITC) in free solution. 
 The IC50 measured for cyclic peptide 9 (0.53 ± 0.05 µM) was essentially the same as 
that found for 6 (0.53 ± 0.06 µM), showing that (as expected) the acetylated hydrazino group 
does not alter significantly the interaction of the mimetic with rHDM2. The KDs for binding 
of biotinylated cyclic peptides 10-12 and the biotinylated linear peptides 16-18 to rHDM2, 
measured by SPR, are shown in Table-1. In addition, the affinity of the linear peptide 19, 
corresponding to the loop of cyclic peptide 7, without the D-Pro-L-Pro template, was 
measured. An IC50 value of 35µM was determined using the competition assay, but the 
affinity was too weak to be determined by ITC. We conclude, therefore, that the constrained 
conformation of the macrocyclic peptide (7), and not just the loop sequence, is important for 
recognition by HDM2. The interactions with rHDM2 of the unmodified linear peptides 13-15 
and the cyclic peptides 6-8, were next studied by ITC. Typical isotherms are shown in 
Figure-4, and the resulting thermodynamic parameters are given in Table-2, and are 
summarized in Figure-5A. 
 Finally, the effects on binding affinities to rHDM2 of substituting each residue in the 
cyclic peptide 7 (except the template residues D-Pro-L-Pro) by alanine were determined (an 
 6 
alanine scan). The results (Table-3) show that the most pronounced losses in affinity (>300 
fold) are seen upon substituting either 6Cl-Trp3 or Phe1, while substitutions of Leu4, Asp5 or 
Trp6 each caused ~10 fold losses in affinity. The Glu2Ala and Glu7Ala mutants also show 
reduced affinities, although these side chains are solvent exposed, do not contact HDM2, and 
so are not expected to contribute significantly to binding.[9] In these two cases, however, the 
solubility of the peptides in water is dramatically reduced, and both peptides aggregate even 
at low concentrations in aqueous solution, as evidenced by extremely broad 1H NMR signals 
in spectra measured in aqueous solution (data not shown). Also, the ITC data for these two 
mutants showed biphasic isotherms, which were not consistent with a simple 1:1 binding 
model, although inhibitory activity could be detected by SPR (not shown). The altered 
binding affinities for these two mutants, therefore, reflect complex processes arising from a 
major change in the physical properties of the peptides, affecting solubility and aggregation. 
 
Computational studies. As an aid in the characterization of the electronic nature of the 
interactions between the three linear p53-derived peptides (13-15), and three cyclic ß-hairpin 
peptidomimetics (6-8) and HDM2, we have used several strategies involving computational 
quantum chemistry and hybrid quantum/classical electrostatic methods (see Supporting 
Information, computational methods).  
 First, unconstrained density functional theory optimizations were performed on each 
ligand, to obtain accurate structure and electronic property data.  These data were also used 
for subsequent hybrid-classical electrostatic studies.  Unconstrained geometry searches were 
also performed on ligand plus select surrounding HDM2 residue fragments, to better 
understand the electronic nature of these interactions. 
 Starting from the structure of the HDM2:7 complex (PDB 2AXI), assessment of vdW 
interactions between the ligand containing 6-X-Trp (where X=H, Cl or Me) and HDM2 
Phe86/Phe91 residues, was carried out.  Assessments were made for both the crystal structure 
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conformation, and following an unconstrained geometry optimization of each complex.  
Computations were performed in vacuum, as well as low dielectric environment to mimic the 
protein. The results are shown in Table-4. 
 The indole NH of the 6-X-Trp residue in each of the three ligands 3, 7, and 13a bound 
to HDM2 (in PDB 2GV2, 2AXI and 1YCR) is close enough (2.7 Å for Cl...N in 2AXI) to 
hydrogen bond to the backbone carbonyl group of Leu54 in HDM2 (Figure-1). We, therefore, 
used the X-ray structure of the 7:HDM2 complex (2AXI) and computational methods to 
estimate the strength of this ligand-protein H-bond, how it changes when the 6-X-Trp 
substituent is varied, and thus whether it is likely to contribute to the stabilization of the 
ligand-HDM2 complex. The results of these calculations are shown in Table-5. 
 Next, hybrid quantum/classical electrostatic methods were used to investigate 
computationally the entire ligand-HDM2 complex, for each of the modified ligands 
considered.  These computations incorporate the accurate QM structural and atomic charge 
data for the peptides. The calculated total binding energy (ΔEtot binding) was calculated using the 
Adaptive Poisson-Boltzmann Solver (APBS) method[11], which includes both electrostatic 
interactions (ΔEtotal elect) arising from both coulombic (ΔEelect) and polar solvation (ΔEsolvation) 
contributions, as well as non-polar solvation effects (ΔΕtotal non-elect) arising from cavitation and 
dispersion terms, i.e.: 
ΔEtot binding =  ΔEtotal elect +  ΔΕtotal non-elect           (1) 
where,  ΔEtotal elect = ΔEelect + ΔEsolvation          (2) 
Each of these energies are evaluated for the complex (Ecomplex) and for the separated protein 
(Eprotein) and the ligand (Eligand), i.e.: 
ΔE   =  Ecomplex  - ( Eprotein  +  Eligand )               (3) 
 
The results of these calculations are represented in schematic form in Figure-5. 
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Discussion 
Background information. The binding of HDM2 to helical and hairpin peptide ligands 
represents an interesting model system with which to explore the molecular basis of specific, 
high affinity protein-ligand and protein-protein interactions. Although such interactions are 
key to many biological processes, it is still extraordinarily difficult to use high-resolution 
structural information on proteins and the complexes they form, to either predict binding 
affinities, or to design de novo new molecules able to bind selectively and with high affinity 
to a chosen target. 
 In previous work, we showed how cyclic ß-hairpin peptidomimetics such as 7 could 
be designed to mimic the helical epitope in p53, and bind with high affinity to HDM2. Four 
crystal structures are currently available of peptide ligands bound to HDM2, including a) 
with bound linear p53-derived peptide 13a (pdb 1YCR, resolution 2.6Å)[5], b) with bound 
phage-derived linear peptides, including 3 (pdb 1T4F and 2GV2, resolution 1.8Å)[7, 8], and c) 
with bound cyclic peptide 7 (pdb 2AXI, resolution 1.4Å)[9]. These structures reveal that 
residues along one face of the helix in 13a (Phe19, Trp23 and Leu26) and the analogue 3 (Phe1, 
6-chloro-Trp5 and Leu8), dock into three hydrophobic pockets on the surface of HDM2. In 
addition, residues Phe1, 6-chloro-Trp3 and Leu4 in one strand of the ß-hairpin mimetic 7 dock 
similarly into the corresponding pockets on HDM2. The relative positions of both the HDM2 
residues, and the Phe/(Cl)Trp/Leu triad in each ligand are very similar (with some 
qualification - see below) in the three structures 1YCR+2GV2+2AXI (see Figure-6). 
 NMR studies have also provided important insights into the complex dynamical 
behavior of the p53-HDM2 system. Firstly, the N-terminal region of p53 (approx. residues 1-
100 of the 393 amino acid protein), which includes the transactivation domain and a proline-
rich region, is devoid of tertiary structure and largely missing secondary structure elements in 
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aqueous solution.[12, 13] N-terminal p53-derived peptides adopt at best loosely folded, or 
nascent helices, and only become fully helical upon binding to HDM2.[14] Secondly, ligand-
free HDM2 also appears by NMR to undergo significant conformational changes upon 
binding to p53, and to be considerably more flexible than the ligand-bound form.[15, 16] 
Moreover, the p53 binding cleft in ligand-free HDM2 is mostly occluded as a result of the 
inward movement of two helices comprising the walls of the p53 binding cleft.[16] Before 
ligand binding can occur, these two sub-domains must move apart to expose the deep 
hydrophobic p53 binding pockets. In addition, the N-terminal segment of apo-HDM2 folds 
back, forming a lid over the shallow end of the p53 binding cleft, and this must also move 
away to allow access to the binding site.[17] 
 These data suggest a complex mechanism of p53 binding to HDM2, which involves 
both displacement of water molecules from the surface of p53 and HDM2, and substantial 
conformational changes in both binding partners. In particular, the p53-binding pockets on 
HDM2 (once exposed) are quite hydrophobic in nature. The extent of their hydration prior to 
ligand docking is so far unknown, but would be expected to have a significant influence upon 
the thermodynamics of ligand binding.[18] In contrast, the cyclic ß-hairpin p53 
peptidomimetics appear by NMR to adopt relatively stable hairpin structures in free solution, 
so only relatively minor conformational changes appear necessary upon binding to HDM2.[10] 
Of course, these dynamical properties complicate a structure-based interpretation of 
thermodynamic binding data. However, one aim of the present work was to characterize the 
differences in standard free energies of binding to HDM2 of the three linear p53-derived 
peptides (13-15), and three cyclic ß-hairpin peptidomimetics (6-8). Given the close 
similarities of the final ligand-protein structures, the data should then be informative for the 
differences in binding of the linear vs. cyclic peptides, and also for the interactions the 6-
substituted tryptophans (6-Cl and 6-Me) experience within the Trp23 binding pocket. 
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Substituent effects upon ligand binding. Binding affinities were measured experimentally 
using two different methods, surface plasmon resonance (SPR) and isothermal titration 
calorimetry (ITC). Given that very similar, but non-identical ligands were used for the two 
studies (Figure-3), the close agreement observed between the affinities determined by these 
two different methods is reassuring (Tables-1 and -2).  
 We have shown here that the ligand side chain contributing most to binding of 
mimetic 7 with HDM2 is that of 6-chloro-Trp3 (Table-3). We have also shown that the 6-Cl 
substituent on the indole ring of this ligand enhances the binding affinity, compared to the 
unsubstituted case, by almost a factor of 2-3, whereas a 6-Me substituent weakens the binding 
interaction, also by almost a factor of two (Table-1 and -2). This result was unexpected, since 
earlier studies with the linear peptides (2-5) showed that introducing a 6-Cl, 6-Me or 6-F 
substituent in the Trp side chain improved ligand affinity (IC50) substantially by factors of 63, 
31 and 22, respectively.[6] We have also studied here the affinities to HDM2 of p53-derived 
linear peptides (13-15, and 16-18) containing 6-Cl and 6-Me substituents in the Trp side 
chain. Now, by introducing either a 6-Cl or a 6-Me group, affinity (KD) improves by factors 
of up to 12 and 6, respectively (Table-1), results that are in much closer agreement to those 
obtained earlier with the analogues 2-5. However, the question then arises, why do the 
substituent effects on affinity differ so much in the linear vs. cyclic peptide ligands? The 
answer to this question is most likely linked to the quite different thermodynamic signatures 
that the linear and cyclic peptides show upon binding to HDM2. 
 
Thermodynamic signatures.  The standard free energies of binding of the linear (13-15) and 
cyclic (6-8) peptides were measured by ITC. Although the binding of both is enthalpically 
driven (negative ΔHo), the enthalpic effects are 3-4 fold  (i.e. ca. 10 kcal/mol) higher with the 
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linear peptides at 298 K (Table-2; Figure-5A). This presumably arises because the flexibility 
of the linear peptide allows enthalpically more favorable interactions in the complex than is 
possible for the more rigid cyclic peptide. 
 Also, the binding of each cyclic peptide is characterized by a positive entropic term 
TΔSo, whereas that of the linear peptides shows a negative TΔSo of similar magnitude. In 
other words, the constrained ligand experiences a reduced entropic penalty upon binding, as 
one might expect. One of the prime arguments frequently cited when designing 
conformationally constrained peptide ligands for protein receptors, is that the constrained 
molecule should suffer a smaller entropic penalty upon receptor binding, in comparison to the 
flexible linear peptide ligand, and this is certainly observed in this system. But it is also clear 
that the entropic penalty in binding the flexible linear peptide is largely offset in this system 
by an enhanced enthalpic gain upon interaction with HDM2. 
 When two hydrophobic molecules associate in aqueous solution, with consequent 
burial of hydrophobic surface, a positive standard entropy of binding (TΔSo) is expected, due 
to release of ordered water molecules from the hydrophobic surfaces of protein and ligand 
into bulk water. Examples of negative values of both ΔHo and TΔSo in the association of 
molecules in water (with negative ΔGo) are not exceptional, and have been known for a long 
time[19]. Although not consistent with just hydrophobic interactions, a negative standard 
entropy of binding may arise, for example, when attractive van der Waals interactions and 
hydrogen bonds are formed in the low dielectric environment of the protein interface, and/or 
due the requirement for folding of the linear p53-derived peptide into a regular α-helix upon 
binding. It is again worth emphasizing, however, that the complex dynamical properties of 
the p53/HDM2 system complicate a structure-based interpretation of thermodynamic binding 
data. 
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Theoretical studies - Interactions involving the substituents. Advances in computational 
methods promise to facilitate greatly the complex process of structure-based protein ligand 
design and an understanding of ligand-receptor interactions. Theoretical studies were, 
therefore, undertaken in an attempt to analyze in a quantitative way the electronic nature of 
the interactions occurring between the various linear and cyclic peptides and HDM2, 
information that might in turn be helpful for a deeper understanding of the substituent effects 
on binding affinity and thermodynamic signatures discussed above. 
 The available X-ray crystal structures (vide supra) suggest (qualitatively at least) that 
similar ligand-HDM2 interactions arise upon binding of both the linear- and cyclic-peptides 
to HDM2. However, upon closer analysis some subtle structural differences become 
apparent. For example, the crystal structure analysis of the HDM2-7 complex identified 
alternate side chain conformations for HDM2 residues Phe86 and Leu57, which are buried 
deep within HDM2 and comprise part of the ligand X-Trp23 binding pocket. The 
energetically important X-Trp side chain of each ligand (where X=H, Cl, Me) binds close to 
both aliphatic (Leu57, Ile61, Val93, Ile99 and Ile103) and aromatic (Phe86 and Phe91) side chains 
in HDM2. In particular, the Phe86/Phe91 phenyl hydrogen atoms point towards the ligand-Trp 
indole 6-position (Figure-6).  It seems that in the 2AXI structure, the side chain of Phe86 can 
rotate, compared to its position in 1YCR and 2GV2, most likely due to close interaction with 
the Cl-substituent of the inhibitor 7. A conformational grid search was performed starting 
with the HDM2-7 structure (PDB 2AXI). The results of this analysis (not shown) suggest that 
even in the crystal there is sufficient flexibility in the binding site to allow the Phe86 and 
Phe91 side chains to adopt a wide range of χ2 torsion angles. 
 Starting from the geometry given in the PDB 2AXI structure, the energy of 
interaction was calculated between the 6-substituent on the X-Trp ligand and the nearby 
Phe86/Phe91 residues. While in the gas phase, the interaction energy is 2.4, 1.2, and 0.7 
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kcal/mol for X=Cl, X=Me, and X=H, respectively, in a protein-like environment, this 
interaction decreases to 1.5, 0.7, and 0.0, respectively (Table-4). The magnitude of the 
interaction energies between these side chains and the X-Trp does depend upon the precise 
interaction geometries, and in particular upon the dielectric in the binding pocket (see 
Supporting Information). 
 Overall, for 6-X-Trp in all ligands, the calculations suggest that small but significant 
stabilizing vdW interactions on the order of 0.7-1.5 kcal/mol can occur between either a 
polarizable Cl substituent or a Me substituent and the partial positive charge of the phenyl 
hydrogens of the Phe86/Phe91 side chains. However, with the methods available at present, the 
calculations likely are not sufficiently accurate to provide a reliable ranking of such 
individual small interaction energies, particularly given that the entire protein cannot be 
considered in this analysis. The calculations support the notion that introducing the 6-Cl or 6-
Me substituents into the energetically important Trp binding pocket should provide enhanced 
ligand affinity due to the resulting vdW interactions with HDM2 residues Phe86 and Phe91 
and provide a quantitative estimate for these interactions. This only accounts in part for the 
total effect on affinity of the substitutions in Trp observed with the cyclic and linear peptides. 
Other factors must also have an important role.  For example, it can be observed in the crystal 
structure that there are also important vdW interactions arising from other residues in the 
binding site just above the plane of the indole ring (Figure-7), which also contribute to the 
overall stability of the ligand in the binding site.  Depending on the substitution (X = Cl, CH3, 
H), the resulting electronic nature of the π system will change, with corresponding 
strengthening or weakening of these vdW interactions. 
 
Theoretical studies - Hydrogen bonds.  The indole NH of the 6-X-Trp residue in all three 
ligands (3, 7, and 13a) is close enough (2.7 Å for Cl...N in 2AXI) to hydrogen bond to the 
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backbone carbonyl group of Leu54 in HDM2 (Figure-1). We therefore used computational 
methods to estimate the strength of this ligand-protein H-bond and thus whether it is likely to 
contribute to the stabilization of the ligand-HDM2 complex. In the case of Cl substitution, the 
calculations predict that this interaction is worth 2.5 kcal/mol in a protein-like dielectric 
environment (Table-5), and would be even less in an environment with a dielectric similar to 
that of bulk water. Interestingly, theory also predicts that introduction of the 6-Cl substituent 
on the indole ring will strengthen the H-bond in the crystal structure geometry by about 0.4 
kcal/mol, compared to the ligand containing no substituent. A similar but smaller (≈0.2 
kcal/mol) strengthening effect is also seen when a 6-Me substituent is introduced. 
 These results provide a quantitative estimate of the stabilizing influence of one 
ligand-protein hydrogen bond, in an environment with a protein-like interior dielectric. By 
extension it seems likely that the formation of multiple H-bonds along the backbone of the 
linear p53-derived peptide, as it folds into a helical conformation and binds to HDM2, may 
well have a significant impact on the thermodynamics of the overall binding reaction. The 
calculations furthermore highlight another way in which the 6-X substituent in the ligand can 
influence the stability of the ligand-HDM2 complex, namely, through effects on H-bonding 
in addition to the direct vdW interactions discussed above. 
 
Theoretical studies - Calculated binding energies. Currently, it remains a major technical 
challenge to accurately predict ligand-receptor binding affinities using theoretical methods. 
Nonetheless, the available structural and experimental binding data make these ligand-HDM2 
interactions an interesting model system to examine, using state-of-the-art theoretical 
methods. The approach we have used here to calculate binding energies, and in particular, 
binding energy differences between the various ligands of HDM2, involves solving the 
linearized Poisson-Boltzmann equation to determine electrostatic interaction energies. The 
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calculated total binding energy differences (ΔEtot binding) provided by the Adaptive Poisson-
Boltzmann Solver (APBS) method[11] includes both electrostatic interactions (ΔEtotal elect) 
arising from both coulombic (ΔEelect) and polar solvation (ΔEsolvation) contributions, as well as 
non-polar solvation effects (ΔΕtotal non-elect) arising from cavitation and dispersion terms. The 
calculations, however, do not fully account for the changes in entropy that occur upon 
binding, and so the calculated binding energy differences (ΔEtot binding) are not quantitatively 
comparable to the experimental standard free energy of binding (ΔGo), nor to experimental 
ΔHo and TΔSo values. The values of both ΔEtot binding and ΔΔHo will certainly be influenced by 
changes in the electrostatic properties of the bound ligand, as the structure is varied (e.g. 
linear vs cyclic ligand, chloro- vs methyl-substituent etc.), and so correlations between 
binding energy differences predicted by theory and those observed experimentally might be 
expected, and are indeed found, as discussed below. 
 With this in mind, a comparison was made of the experimental thermodynamic 
parameters (Table-2) and the calculated electrostatic interaction energy differences. The 
results of the comparison are summarized in Figure-5, and show interesting correlations 
betwen experimental and theoretical data. For example, a stronger total binding energy 
(ΔΕtotal non-elect) is calculated for the linear (13a) compared to the cyclic peptide (7) (Figure-
5B, red bars), which correlates with the larger ΔHo values determined for the linear peptides 
compared to the cyclic peptides by ITC (Figure-5A, orange bars). Interestingly, this is shown 
to arise computationally from a difference in the non-polar contributions to solvation (ΔEtotal 
nonelect) in the two systems (green bars), since the direct ligand-receptor total electrostatic 
interactions (ΔEtotal elect) are not largely different (Figure-5B, orange bars). Thus, ΔEtotal elect  =   
ΔEelect + ΔEsolvation (see above) and so whereas ΔEelect (Figure-5B, yellow hatched) is more 
favorable in the linear vs. cyclic molecules, ΔEsolvation (Figure-5B, blue hatched) is also more 
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unfavorable in the linear vs. cyclic molecules, with the net result (stated above) that ΔEtotal elect 
(orange bars) are not largely different for these two systems. 
When we consider the changes in the calculated total binding energy (ΔEtot binding) 
caused by varying the substituent in the 6-X-Trp residue (relative to the case where X=H), a 
small increase is found for both substituents (Cl and Me) (Figure-5C, red bars).  However, 
the advantage of having X=Cl over X=Me is predicted by calculation to be more pronounced 
in the cyclic ligands than in the linear ligands. Thus, the gain in calculated total binding 
energy is much smaller for X=Me in the cyclic case, whereas introducing Cl and Me gives a 
significant gain for the linear ligand. Indeed, upon introducing X=Me, the ΔEtotal elect 
component is unfavorable for both the linear and cylic peptides, but much more so in the 
cyclic compared to the linear peptide (Figure 5C, orange bars). For this reason, ΔEtot binding is 
also much smaller for the cyclic ligand upon introduction of X=Me. Experimentally, we 
observe that adding either a Me or Cl substituent in the linear peptides increases affinity, 
whereas adding Cl in the cyclic ligand improves affinity but adding Me slightly weakens 
affinity (Table-2). Interestingly, this weakening of affinity observed experimentally upon 
adding Me in the cyclic ligand (but not the linear ligand) is reflected in the results of the 
calculations shown in Figure-5C. This trend can also be illustrated using a surface 
electrostatic representation. Thus, in Figure-8 the calculated differences in molecular 
electrostatic potentials (MEP) are shown for the complexes with linear (top) and cyclic 
(bottom) ligands, for the case X=Me relative to X=H (left side), and for the case X=Cl 
relative to X=H (right side). The largest effects are observed in complexes with the cyclic 
peptides, where additional positive charge is indicated by blue, and additional negative 
charge is indicated by red. We emphasize that the calculations are not sufficiently accurate to 
provide reliable quantitative estimates of such small energetic effects. But the calculations 
 17 
highlight what types of subtle differences in electrostatic properties of the ligands may result 
upon adding either Cl or Me as a substituent in the Trp residue. 
The ability of this theoretical approach to correctly reflect experimentally determined 
thermodynamic features of the binding reactions for this series of peptide ligands and provide 
insights into the electronic nature of the interactions, is notable. Such peptide-protein 
interactions remain interesting targets for the further development of the peptidomimetic 
approach to protein-ligand design, as well as of computational methods for the analysis of 
protein-ligand interactions, especially for the difficult case of discovering protein-protein 
interaction inhibitors. 
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Figure Legends 
Figure-1. TOP, The p53-derived peptide 13a-HDM2 complex (pdb 1YCR, left), and the ß-
hairpin peptidomimetic 7-HDM2 complex (pdb 2AXI, right). The conformation of Phe86 and 
Phe91 side chains (in pink with CPK surface) are also shown.  BOTTOM, close-up view of the 
H-bonding interaction involving the Trp indole NH in 1YCR (left) and 2AXI (right). 
 
Figure-2. Linear peptide antagonists of the p53/HDM2 interaction. 
 
Figure-3. Structures of cyclic ß-hairpin peptidomimetics (6-12), and linear p53-derived 
peptides (13-19) used in this work. The usual single letter amino acid code is used for the 
linear peptides, except for the 6-substituted tryptophan (6Cl- or 6Me-W). 
 
Figure-4. ITC isotherms for the binding of A, linear peptide 13 and B, cyclic peptidomimetic 
7 to rHDM2. 
 
Figure-5. A, Comparison of the experimental thermodynamic signatures of binding to 
rHDM2 for the linear (13-15) vs. cyclic (6-8) peptides. B, Comparison of the calculated 
binding energies determined using the APBS method (see text) for linear vs. cyclic peptides. 
C,  electrostatic binding energy differences determined theoretically for the ligands with 
X=Cl or X=Me, relative to the corresponding peptide containing tryptophan (X=H). 
 
Figure-6. A, Backbone superimposition of the p53-binding pocket in three X-ray crystal 
structures: HDM2+13a (pdb 1YCR); HDM2+7 (pdb 2AXI); HDM2+3 (pdb 2GV2)). The Trp 
and 6Cl-Trp shown in red are derived from the ligands (Trp in 1YCR, and Cl-Trp in 2AXI 
and 2GV2). Only HDM2 residues within 5Å of this (Cl)Trp are shown as stick 
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representations; an alternative view B, shows the residues in HDM2 forming the Trp23 
binding pocket and their nearest distances (in Å) from (Cl)Trp in the ligand. Note the side 
chains of Phe86 and Leu57, adopt alternate conformations in the 2AXI structure. 
 
Figure-7. Shown are the interactions of Cl-Trp (in PDB 2AXI) with the non-aromatic side 
chains of HDM2 (Ile57=yellow, Ile61=green, Ile99=pink; Val93=red), and Leu4=orange from 
the ligand (compare Figure-6). 
                
Figure-8. Display of HDM2-ligand complexes. Set top represent the molecular electrostatic 
potential map difference between X=Cl and X=H (left side) and between X=Me and X=H 
(right side) in the linear peptide bound (as in 1YCR), and bottom display the molecular 
electrostatic potential map difference between X=Cl and X=H (left side) and between X=Me 
and X=H (right side) in the cyclic peptide bound (as in 2AXI). 
 
 
 22 
Table-1. Dissociation constants (KD) determined by SPR for the interactions of 10-12 and 
16-18 with rHDM2 at 298K. Measurements were performed in triplicate and the mean and 
deviations are shown. 
Ligand 
(substituent) 
KD (µM) Normalized 
1/KD 
(ΔG Kcal/mol) 
10 (X = H) 
11 (X = Cl) 
12 (X = Me) 
0.12 ± 0.01 
0.065 ± 0.02 
0.27 ± 0.07 
1 
1.85  (0.36) 
0.43  (-0.50) 
16  
17 (+Cl) 
18 (+Me) 
0.67 ± 0.07 
0.055 ± 0.005 
0.11 ± 0.01 
1 
12.2 (1.48) 
6.1   (1.07) 
 
 
 
Table-2. Ligand binding to rHDM2 measured by isothermal titration calorimetry at 298K. 
Measurements were performed at least in duplicate and the mean and deviations are shown.
 Ligand 
(substituent) 
ΔHo 
[Kcal/mol] 
ΤΔS 
[kcal/mol/] 
 
Stoichio-
metry 
KD [µM] 
 
 
Normalized  
1/KD 
(ΔG 
kcal/mol) 
6  (H) 
7  (Cl) 
 8  (Me) 
-4.6±0.1 
-4.6±0.1 
-3.9±0.1 
+5.1±0.2 
+5.8±0.4 
+5.7±0.2 
0.94±0.03 
0.92±0.02 
0.94±0.1 
0.073±0.005 
0.025±0.002 
0.10±0.02 
1.0 
2.92 (0.63) 
0.73 (-0.19) 
13  (H) 
14  (Cl) 
 15  (Me) 
-14.1±0.7 
-15.8±0.6 
-14.7±0.6 
-5.4±0.7 
-6.1±0.5 
-5.1±0.7 
0.91±0.1 
1.01±0.1 
1.00±0.09 
0.43±0.03 
0.08±0.01 
0.09±0.06 
1.0 
5.38 (1.00) 
4.78 (0.93) 
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Table-3. The effects of an alanine scan with inhibitor 7 (residues 1 to 8 are shown). The D-
Pro-L-Pro template was not altered. Mean values for ΔH, TΔS and Kd are derived from at 
least two independent ITC experiments. Mean inhibitory activity (IC50) and standard 
deviations derive from at least three independent SPR-based inhibition assay experiments. - 
indicates an interaction too weak to analyze, or with peptides 21 and 26 showing biphasic 
behavior. 
 
                                      residue 
Peptide 1 2 3 4 5 6 7 8 ΔH [Kcal/mol] 
TΔS 
[Kcal/mol] 
Kd [µM] 
(ITC) 
IC50 [µM] 
(SPR) 
7     F E (6Cl)W L D W E F -4.6 ± 0.1 +5.8 ± 0.2 0.025±0.002 0.14±0.06 
20 A E (6Cl)W L D W E F -4.8 ± 0.2 +2.1 ± 0.2 9.0 ± 0.4 7 ± 3 
21 F A (6Cl)W L D W E F - - - 1.1 ± 0.4 
22 F E A L D W E F - - - 23 ± 8 
23 F E (6Cl)W A D W E F -6.1 ± 0.4 +2.7 ± 0.4 0.35 ± 0.04 0.55 ± 0.07 
24 F E (6Cl)W L A W E F -2.2 ± 0.1 +6.7 ± 0.03 0.28 ± 0.03 0.35 ± 0.05 
25 F E (6Cl)W L D A E F -7.3 ± 0.1 +1.5 ± 0.1 0.36 ± 0.01 0.70 ± 0.01 
26 F E (6Cl)W L D W A F - - - 0.60 ± 0.1 
27 F E (6Cl)W L D W E A -8.4 ± 0.2 +1.2 ± 0.2 0.095 ± 0.003 0.18 ± 0.02 
 
 
Table-4.  Calculated interaction energies (kcal/mol) between Phe86/Phe91 of HDM2 and X-
Trp in the cyclic peptidomimetics (6-8), in the crystal structure PDB 2AXI.  
 
 
 
 
 
 
 
1X---Phe86 distance of 2 closest Phe H’s; X---Phe91 distance of 2 closest Phe H’s. 
Shortest distances found in the crystal structure are 3.4 Å and 3.6-3.7 Å, respectively. 
 
E (kcal/mol) 
 
Shortest X to Phe hydrogen Distances (Å)1 Trp-X 
gas  
phase 
ε=4 X---Phe86-H X---Phe91-H 
X=H 0.7 0.0 2.7, 2.8  2.2, 2.4 
X=Cl 2.4 1.5 3.3, 3.1  2.9, 2.8 
X=Me 1.2 0.7 2.7, 3.0 2.3, 2.4  
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Table-5.  Assessment of H-bond energies (kcal/mol) and distances between Leu54 of HDM2 
and X-Trp in the cyclic peptidomimetics 6-8.  
 
1 M06-2X/DZ(2d,p) theory was used. Calculated using the crystal structure (2AXI), and 
with the substitutents X=H and X=CH3 hydrogen bond optimized. 
 
 
 
Table-6. Computational results of energetic contributions to the binding energy of the HDM2 
receptor and the p53 peptidomimetics 2AXI-(6-8) and 1YCR-(13-15). Results are expressed 
relative to tryptophan (X=H) in terms of a (∆∆) energy difference. 
 
Complex ∆∆Etot elect1 ∆∆Etot nonelect2 ∆∆Etot bind3 ∆∆EExpt4 
2AXI-7 (X=Cl) -0.95 -4.14 -5.09 -0.65 
2AXI-8 (X=Me)  1.83 -3.12 -1.30 0.17 
1YCR-14 (X=Cl) -1.51 -1.90 -3.42 -0.72 
1YCR-15 (X=Me)  0.34 -3.03 -2.69 -0.66 
1Total electrostatic contribution. 
2Total non-electrostatic contribution 
3Total binding energy 
4Experimental binding energy 
 
 
 
 
H-bond Energy, Dipole Moment, 
& N—H----O distances1 
Energy 
(Kcal/mol) 
H-bond distances 
System 
 
2AXI + 
X-Trp 
ε=1 ε=4 
Dipole 
(D) 
N-O N—H/H- -O 
X=H 4.5 2.1 3.8 2.96      1.02 / 2.00 
X=Cl 5.2 2.5  5.0 2.92     1.01 / 2.06 
X=Me 4.6 2.3  4.9 2.88     1.01 / 2.06 
